Gene · 11065
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The protective up-regulation of metallothionein-2A in intervertebral disc degeneration inhibits nucleus pulposus cell ferroptosis through activation of the PI3K/AKT/mTOR pathway. | Cell Death Discov | 2026 | 41741409 | PubTator, text mining | PubMed |
| Structure-guided analysis and prediction of human E2-E3 ligase pairing specificity. | bioRxiv | 2026 | 41726935 | PubTator, text mining | PubMed |
| Charting the multilevel molecular response to palbociclib in ER-positive breast cancer. | NAR Cancer | 2026 | 41710088 | PubTator, text mining | PubMed |
| Harnessing PDX and PDX 2.0: the next-generation paradigm for precision oncology and translational breakthroughs. | Mol Cancer | 2026 | 41699647 | PubTator, text mining | PubMed |
| SUMOylation of UBE2C facilitates hepatocellular carcinoma proliferation and invasion via the MAPK pathway. | Transl Cancer Res | 2026 | 41674974 | PubTator, text mining | PubMed |
| NFATc3 Enhances DREAM Complex-Driven Transactivation. | bioRxiv | 2026 | 41648269 | PubTator, text mining | PubMed |
| Single-cell analysis identifies ATC-like cells driving progression in relapsed follicular thyroid carcinoma. | Endocrinology | 2026 | 41631714 | PubTator, text mining | PubMed |
| Transcriptomic insights into the immune dynamics of wild-type mice challenged with SARS-CoV-2 Beta variant. | Lab Anim Res | 2026 | 41606700 | PubTator, text mining | PubMed |
Collaborative breakthroughs in precision diagnosis and treatment of nasopharyngeal cancer: Biomarker‑driven screening and endoscopic minimally invasive surgery reshape the new paradigm of early intervention (Review). | Oncol Rep | 2026 | 41574726 | PubTator, text mining | PubMed |
| Identification of a Cuproptosis-Related Molecular Signature for Predicting Biochemical Recurrence in Prostate Cancer. | Comb Chem High Throughput Screen | 2026 | 41568495 | PubTator, text mining | PubMed |
| A bird's eye view on potential molecular prognostic markers in retinoblastoma: insights for precision oncology. | Ophthalmic Genet | 2026 | 41542805 | PubTator, text mining | PubMed |
| Integrated Network Analysis Reveals a Directly Regulatory Network of FOXM1 Associated With the Cell Cycle in Lung Adenocarcinoma. | Bioinform Biol Insights | 2026 | 41541229 | PubTator, text mining | PubMed |
| Integrating multiple key molecules in uveal melanoma to uncover metastatic and immune microenvironment-related gene signatures. | Int J Ophthalmol | 2026 | 41523997 | PubTator, text mining | PubMed |
| Dysregulation of atrazine-associated core gene networks and risk prediction in human cancers: Insights from integrated transcriptomics and network toxicology analyses. | Ecotoxicol Environ Saf | 2026 | 41512780 | PubTator, text mining | PubMed |
| Single-cell analysis identifies a stemness-associated tumor cell subpopulation and develops a prognostic scoring model in esophageal squamous cell carcinoma. | Transl Oncol | 2026 | 41496411 | PubTator, text mining | PubMed |
| MAZ-Mediated ubiquitin-conjugating enzyme E2C upregulation promotes breast cancer progression via the MAPK signaling pathway. | Transl Oncol | 2026 | 41496410 | PubTator, text mining | PubMed |
| UBE2C/PTTG1 Regulates PANoptosis, Ferroptosis, and Autophagy to Improve Renal Ischemia-Reperfusion Injury. | FASEB J | 2026 | 41467880 | PubTator, text mining | PubMed |
| UBE2C-PI3K/AKT-mediated upregulation of MTHFD2 promotes tumor progression in hepatocellular carcinoma. | Int Immunopharmacol | 2026 | 41456492 | PubTator, text mining | PubMed |
| Halorotetin B, A Novel Terpenoid Compound Derived from Marine Ascidian, Suppresses Tumor Growth by Targeting the Cell Cycle Regulator UBE2C. | Adv Sci (Weinh) | 2026 | 41387196 | PubTator, text mining | PubMed |
| Action mechanisms of progesterone in managing bone loss in periodontitis: An in vitro study. | Arch Oral Biol | 2026 | 41138344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11065/papers?page=3